1. Home
  2. MCBS vs TBPH Comparison

MCBS vs TBPH Comparison

Compare MCBS & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$35.24

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$17.04

Market Cap

908.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
TBPH
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
908.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
MCBS
TBPH
Price
$35.24
$17.04
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$33.00
$18.40
AVG Volume (30 Days)
59.0K
373.1K
Earning Date
04-24-2026
05-04-2026
Dividend Yield
3.63%
N/A
EPS Growth
4.76
279.13
EPS
1.53
N/A
Revenue
N/A
$15,386,000.00
Revenue This Year
$36.78
$8.46
Revenue Next Year
$2.44
N/A
P/E Ratio
$22.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.53
$13.08
52 Week High
$37.46
$21.03

Technical Indicators

Market Signals
Indicator
MCBS
TBPH
Relative Strength Index (RSI) 45.74 62.41
Support Level $35.06 $16.80
Resistance Level $35.30 $17.17
Average True Range (ATR) 0.66 0.05
MACD -0.10 0.01
Stochastic Oscillator 35.12 70.73

Price Performance

Historical Comparison
MCBS
TBPH

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: